These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3691134)
1. Low-dose propionhydroxamic acid therapy in infection-induced stones. Colussi G; Surian M; De Ferrari ME; RombolĂ G; Rolando P; Minetti L Contrib Nephrol; 1987; 58():230-2. PubMed ID: 3691134 [No Abstract] [Full Text] [Related]
2. Physicochemical changes of urine environment on propionhydroxamic acid therapy. Bruno M; Marangella M; Tricerri A; Martini C; Linari F Contrib Nephrol; 1987; 58():207-11. PubMed ID: 3691128 [No Abstract] [Full Text] [Related]
3. Propionhydroxamic acid in the management of struvite urinary stones. Puppo P; Germinale F; Bottino P; Ricciotti G; Giuliani L Contrib Nephrol; 1987; 58():201-6. PubMed ID: 3691127 [No Abstract] [Full Text] [Related]
10. Acetohydroxamate in struvite stones: in vivo study. Aroldi A; Graziani G; Castelnovo C; Colussi G; Surian M; Mandressi A; Mascheroni E; Pazardjiklian I; Pagano A; Ponticelli C Proc Eur Dial Transplant Assoc; 1983; 20():469-72. PubMed ID: 6657671 [TBL] [Abstract][Full Text] [Related]
11. Propionhydroxamic acid in the treatment of infected complex renal calculosis. Di Silverio F; Gallucci M; Alpi G; La Pera G; Cassanelli A Panminerva Med; 1987; 29(2):169-74. PubMed ID: 3627818 [No Abstract] [Full Text] [Related]
12. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. Griffith DP; Gibson JR; Clinton CW; Musher DM J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones. Martelli A; Buli P; Spatafora S Urology; 1986 Nov; 28(5):373-5. PubMed ID: 3787895 [TBL] [Abstract][Full Text] [Related]
14. New treatment for struvite urinary stones. Smith LH N Engl J Med; 1984 Sep; 311(12):792-4. PubMed ID: 6472369 [No Abstract] [Full Text] [Related]
15. Tolerance and side effects of propionhydroxamic acid. Di Silverio F; Gallucci M; Alpi G; Ricciuti GP; Fini D; Molinari C Contrib Nephrol; 1987; 58():215-8. PubMed ID: 3691131 [No Abstract] [Full Text] [Related]
16. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative. Takeuchi H; Kobashi K; Yoshida O Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228 [TBL] [Abstract][Full Text] [Related]
17. Infectious nephrolithiasis: results of treatment with methenamine mandelate. Jeantet A; Thea A; Ferrando U; Gaido M; Rotunno M; Martini PF; Vercellone A Contrib Nephrol; 1987; 58():233-5. PubMed ID: 3691135 [No Abstract] [Full Text] [Related]
18. [The prognosis of patients with struvite calculi with remaining/recurrent calculi and treatment refractory urinary tract infections]. Janitzky V; Brundig P; Haerting R Z Urol Nephrol; 1989 Dec; 82(12):653-9. PubMed ID: 2629420 [TBL] [Abstract][Full Text] [Related]